Feedback PLC Bleepa builds on robust data management security
19 Gennaio 2021 - 8:00AM
RNS Non-Regulatory
TIDMFDBK
Feedback PLC
19 January 2021
REACH
Feedback plc
Bleepa builds on robust data management security
-- Cyber Essentials Plus Certified
-- ISO 27001 compliant
London, 19 January 2021: Feedback plc (AIM: FDBK, "Feedback" or
the "Company"), the specialist medical imaging technology company,
today announces it has bolstered its data management security with
certification of Cyber Essentials Plus and ISO 27001 for its
flagship imaging-based communication platform, Bleepa. The enhanced
data management protection will provide customers and clinicians
with added confidence in the safety of Bleepa's data security.
Bleepa, a secure instant messaging platform which facilitates
the sharing of clinical grade medical images between personal
devices, is an essential tool to enable remote and secure
communications between clinicians and their teams. Security of data
is of the utmost importance for remote communications and Feedback
continuously reviews and updates its security to comply with
international standards.
The Cyber Essentials Plus audit is a UK Government backed scheme
to enable organisations to guard against a whole range of the most
common cyber-attacks and demonstrates a commitment to cyber
security.
ISO 27001 is the international standard that sets out the
specification for an information security management system (ISMS).
Its best-practice approach helps organisations manage their
information security by addressing people and processes as well as
technology.
Both certificates are sought by the Company's healthcare
customers and will bolster customer confidence in the security of
the Bleepa platform.
Dr Tom Oakley, CEO of Feedback, commented:
"Feedback seeks to liberate frontline clinicians from
inadequate, cumbersome operational systems by safely simplifying
how they communicate with each other and how they access
information about patients, most notably medical imaging. The
emphasis here is on safety. As a medical device manufacturer, we
already adhere to stringent quality processes that comply with ISO
13485, however, being a digital medical device brings new
challenges to safety and quality that are not reflected in
traditional medical device certification. We have sought to address
these challenges and demonstrate our commitment to data security as
rigorously as the processes which we apply to ensuring quality.
Cyber Essentials Plus and ISO 27001 confirm the security of Bleepa
as a platform just as ISO 13485 confirms the quality and safety of
its manufacture. This combined certification is testament to our
commitment to providing clinicians with the right tools for the job
and will give customers confidence about the security of data on
the platform."
-Ends-
Enquiries:
Feedback plc +44 (0) 20 3997 7634
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated
Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236 or
Johnson 07884 664 686
Notes to editors
Feedback plc (AIM: FDBK) is a medical imaging technology
business. Its core product, Bleepa, is a revolutionary medical
imaging communications app, providing an easy-to-use, high quality
tool to enable remote and secure communications between front-line
clinicians and teams. Importantly, it is the only CE marked medical
imaging communications platform on the NHSx clinical communications
tools framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS") based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care facilitators. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of diagnosis.
About Reach announcements
This is a Reach announcement. Reach is an investor communication
service aimed at assisting listed and unlisted (including AIM
quoted) companies to distribute media only / non-regulatory news
releases into the public domain. Information required to be
notified under the AIM Rules for Companies, Market Abuse Regulation
or other regulation would be disseminated as an RNS regulatory
announcement and not on Reach.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRABPMLTMTIBBBB
(END) Dow Jones Newswires
January 19, 2021 02:00 ET (07:00 GMT)
Grafico Azioni Feedback (LSE:FDBK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Feedback (LSE:FDBK)
Storico
Da Apr 2023 a Apr 2024